Allopurinol use in pregnancy in three women with inflammatory bowel disease: Safety and outcomes: A case series

BMC Gastroenterology

Volumn 13, Issue 1, 2013, Pages

  Fazal, Muhammad W ^a   Doogue, Matt P ^b   Leong, Rupert W ^c   Bampton, Peter A ^d   Andrews, Jane M ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

6 mercaptopurine; Allopurinol; Azathioprine; Inflammatory bowel disease; Pregnancy; Teratogen; Ulcerative colitis

Indexed keywords

ADALIMUMAB; ALLOPURINOL; AZATHIOPRINE; CYCLOSPORIN; FOLIC ACID; MESALAZINE; PREDNISOLONE; STEROID; THIOPURINE METHYLTRANSFERASE;

ABSCESS; ADULT; ARTICLE; CASE REPORT; COLON PERFORATION; COLON RESECTION; CROHN DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; FISTULA; HOSPITAL ADMISSION; HUMAN; ILEOSTOMY; INFLAMMATORY BOWEL DISEASE; INGUINAL HERNIA; ISCHIORECTAL ABSCESS; LETHARGY; NAUSEA; PERINEAL FISTULA; PREGNANCY; ULCERATIVE COLITIS;

ADULT; ALLOPURINOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 84890281267     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-13-172     Document Type: Article

References (22)

1. Elion GB. The purine path to chemotherapy. Science 1989, 244:41-47. 10.1126/science.2649979, 2649979.
2. Sparrow MP, Hande SA, Friedman S, Lim WC, Reddy SI, Cao D, Hanauer SB. Allopurinol safely and effectively optimizes thioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther 2005, 22(5):441-446. 10.1111/j.1365-2036.2005.02583.x, 16128682.
3. Sparrow MP. Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease. Gastroenterol Hepatol (NY) 2008, 4(7):505-511.
4. Dubinsky MC, Yang H, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 2002, 122(4):904. 10.1053/gast.2002.32420, 11910342.
5. Fujii T, Nishimura H. Comparison of teratogenic action of substances related to purine metabolism in mouse embryos. Jpn J Pharmacol 1972, 22(2):201-206. 10.1254/jjp.22.201, 4538410.
6. Product information. Zyloprim 1990, Burroughs Wellcome.
7. Hoeltzenbein M, Stieler K, Panse M, Wacker E, Schaefer C. Allopurinol use during pregnancy - outcome of 31 prospectively ascertained cases and a phenotype possibly indicative for teratogenicity. PLoS ONE 2013, 8(6):e66637. 10.1371/journal.pone.0066637, 3686712, 23840514.
8. Kozenko M, Grynspan D, Oluyomi-Obi T, Sitar D, Elliott AM, Chodirker BN. Potential teratogenic effects of allopurinol: a case report. Am J Med Genet 2011, 155A(9):2247-2252.
9. Seinen ML, de Boer NK, van Hoorn ME, van Bodegraven AA, Bouma G. Safe use of allopurinol and low-dose mercaptopurine therapy during pregnancy in an ulcerative colitis patient. Inflamm Bowel Dis 2013, 19(3):E37. 10.1002/ibd.22945, 22407929.
10. Awidi AS, Tarawneh MS, Shubair KS, Issa AA, Dajani YF. Acute leukemia in pregnancy: report of five cases treated with a combination which included a low dose of Adriamycin. Eur J Cancer Clin Oncol 1983, 19(7):881-884. 10.1016/0277-5379(83)90051-2, 6684046.
11. O'Donnell R, Costigan C, O'Connell LG. Two cases of acute leukaemia in pregnancy. Acta Haematol 1979, 61(5):298-300. 10.1159/000207676, 111459.
12. Boros SJ, Reynolds JW. Intrauterine growth retardation following third-trimester exposure to busulfan. Am J Obstet Gynecol 1977, 129(1):111-112.
13. Chocair P, Duley J, Simmonds HA, Cameron JS, Ianhez L, Arap S, Sabbaga E. Low-dose allopurinol plus azathioprine/cyclosporin/prednisolone, a novel immunosuppressive regimen. Lancet 1993, 342:83-84. 10.1016/0140-6736(93)91287-V, 8100914.
14. Sparrow MP, Hande SA, Friedman S, Cao D, Hanauer SB. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Clin Gastroenterol Hepatol 2007, 5(2):209-214. 10.1016/j.cgh.2006.11.020, 17296529.
15. Gearry RB, Day AS, Barclay ML, Leong RW, Sparrow MP. Azathioprine and Allopurinol: a two-edged interaction. J Gastroenterol Hepatol 2010, 25(4):653-655. 10.1111/j.1440-1746.2010.06254.x, 20492321.
16. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK, Tekkis PP. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007, 56(6):830-837. 10.1136/gut.2006.108324, 1954859, 17185356.
17. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007, 133(4):1106-1112. 10.1053/j.gastro.2007.07.019, 17764676.
18. Hanan IM, Kirsner JB. Inflammatory bowel disease in the pregnant woman. Clin Perinatol 1985, 12(3):669-682.
19. Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis 2013, 19(1):15-22. 10.1002/ibd.22948, 22434610.
20. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003, 124(1):9-17. 10.1053/gast.2003.50014, 12512024.
21. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990, 99(2):443-446.
22. Jharap B, de Boer NK, Stokkers P, Hommes DW, Oldenburg B, Dijkstra G, van der Woude CJ, de Jong DJ, Mulder CJ, van Elburg RM, van Bodegraven AA. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut 2013, Published Online First: February 19. doi:10.1136/gutjnl-2012-303615.